Freelino

Monoclonal antibodies (mAbs) are used for cancer detection and treatment, developed through the hybridoma technique. This involves fusing B-cells from immunized mice with myeloma cells to produce hybridomas that generate the desired antibody continuously. Monoclonal antibodies offer several advantages in cancer treatment, such as high specificity towards cancer cells, minimized damage to healthy cells, and the ability to be engineered for enhanced effectiveness. They find applications in various diagnostic tests and therapeutic treatments, demonstrating significant advancement in cancer diagnosis and therapy.